Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoquinoline SCHEMBL30286035 | 1.00 | TNF (0.48) | TNFKDM4ECYP3A4LMNACYP1A2 | |
| Isoquinoline SCHEMBL31588723 | 1.00 | TNF (0.48) | TNFKDM4ECYP3A4LMNACYP1A2 | |
| Isoquinoline SCHEMBL29355164 | 1.00 | TNF (0.48) | TNFKDM4ECYP3A4LMNACYP1A2 | |
| Isoquinoline SCHEMBL1536317 | 1.00 | TNF (0.48) | TNFKDM4ECYP3A4LMNACYP1A2 | |
| Isoquinoline SCHEMBL9654 | 1.00 | TNF (0.48) | TNFKDM4ECYP3A4LMNACYP1A2 | |
| SCHEMBL19840327 | 0.97 | TNF (0.52) | TNFKDM4ECYP3A4LMNACYP1A2 | |
| Isoquinoline SCHEMBL9551000 | 0.97 | HTT (0.47) | TNFKDM4ECYP3A4LMNACYP1A2 | |
| Isoquinoline SCHEMBL1558929 | 0.97 | TNF (0.47) | TNFKDM4ECYP3A4LMNACYP1A2 | |
| Isoquinoline SCHEMBL15845111 | 0.97 | TNF (0.47) | TNFKDM4ECYP3A4LMNACYP1A2 | |
| Isoquinoline SCHEMBL20894858 | 0.97 | TNF (0.47) | TNFKDM4ECYP3A4LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1964713-A | Co-use of dopamine-receptor binding compounds | DARPHARMA INC (US) | 2007-05-16 | — | — | CN | claimed |
| CN-111349055-B | Polycyclic compound used as electroluminescent material and application thereof | 烟台显华光电材料研究院有限公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-111662331-B | Phosphine ligand, preparation method thereof and application of phosphine ligand in catalytic synthesis of ortho-tetra-substituted biaryl | 宁波赜军医药科技有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-111662331-A | Phosphine ligand, preparation method thereof and application of phosphine ligand in catalytic synthesis of ortho-tetra-substituted biaryl | 中国科学院上海有机化学研究所 | 2020-09-15 | — | — | CN | disclosed |
| CN-110494434-A | Pyrazolo chlorobenzene based compound, its composition and its application method | HOFFMANN LA ROCHE | 2019-11-22 | — | — | CN | disclosed |
| CN-110433165-A | The combination and its application method of AKT and mek inhibitor compound | GENENTECH INC | 2019-11-12 | — | — | CN | disclosed |
| CN-110437149-A | Natural naphthyl-isoquinolines compound of anti-tumor activity and combinations thereof, application | UNIV DALIAN MINZU | 2019-11-12 | — | — | CN | disclosed |
| CN-110382503-A | Process for preparing ACC inhibitors and solid forms thereof | 吉利德科学公司 | 2019-10-25 | — | — | CN | disclosed |
| CN-110368407-A | A kind of hook branch rattan branches and leaves active component and its preparation method and application | 大连民族大学 | 2019-10-25 | — | — | CN | disclosed |
| CN-106573927-B | Oxyclohepten-2-yl-pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | 豪夫迈·罗氏有限公司 | 2019-09-27 | — | — | CN | disclosed |
| CN-103087105-A | Chiral phosphine ligand and metal catalyst comprising same and application of chiral phosphine ligand and metal catalyst | SHANGHAI INST ORGANIC CHEM | 2013-05-08 | — | — | CN | disclosed |
| CN-1964713-A | Co-use of dopamine-receptor binding compounds | DARPHARMA INC (US) | 2007-05-16 | — | — | CN | disclosed |
| EP-0594795-B1 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT | US SECRETARY UNITED STATES DEP (US) | 2002-02-13 | — | — | EP | disclosed |
| US-5654432-A | NAPHTHYLISOQUINOLINE ALKALOID ISOLATED FROM ANCISTROCLADUS SP. NOVUM VIA ORGANIC SOLVENT EXTRACTION, ACID-BASE PARTITIONING, CENTRIFUGAL PARTITION CHROMATOGRAPHY, AND HPLC USING AN AMINO-BONDED PHASE COLUMN; VIRICIDE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-08-05 | — | — | US | disclosed |
| EP-0695294-A1 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-02-07 | — | — | EP | disclosed |
| US-5455251-A | Treatment of AIDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-10-03 | — | — | US | disclosed |
| WO-1994024108-A1 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-27 | — | — | WO | disclosed |
| EP-0594795-A1 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1994-05-04 | — | — | EP | disclosed |
| EP-0594795-A4 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT. | US SECRETARY UNITED STATES DEP (US) | 1993-12-07 | — | — | EP | disclosed |
| WO-1992018125-A1 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1992-10-29 | — | — | WO | disclosed |